查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1513619

流感診斷市場:全球產業分析，規模，佔有率，成長，趨勢，預測，2024年～2033年

Influenza Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 237 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於全球流感診斷市場的綜合報告。該報告全面評估了主要市場動態，包括驅動因素、趨勢、機會和挑戰，並提供了有關市場結構的詳細見解。

關鍵見解

  • 流感診斷市場規模（2024 年）：18 億美元
  • 預計市值（2033 年）：30 億美元
  • 全球市場成長率（2024-2033 年複合年增長率）：6.1%

流感診斷市場 - 報告範圍：

流感診斷在流感感染的早期檢測、治療和管理中發揮重要作用。這些診斷包括快速流感診斷測試 (RIDT)、逆轉錄聚合?鏈反應 (RT-PCR) 測定和其他分子診斷工具。市場提供各種各樣的診斷設備，可以提供及時、準確的結果，以有效管理醫院、診所、診斷實驗室和家庭醫療機構的流感流行。

市場成長的驅動力是流感流行的增加、醫療保健支出的增加以及診斷技術進步帶來的檢測準確性的提高和診斷時間的縮短。

推動市場成長的因素：

全球流感診斷市場由幾個關鍵因素推動，包括提高人們對流感早期診斷和治療以預防併發症和感染的認識。流感感染發病率的上升以及季節性大流行期間對有效診斷解決方案的需求進一步推動了市場擴張。技術進步，例如高靈敏度和特異性分子診斷工具的開發，正在提高檢測率並縮短週轉時間，從而推動市場成長。此外，擴大採用現場檢測和家庭診斷解決方案，為市場進入者接觸更多患者群體開闢了新途徑。

市場限制因素：

儘管成長前景廣闊，流感診斷市場仍面臨監管合規、報銷政策和替代診斷競爭等方面的挑戰。有關診斷設備的製造、銷售和使用的嚴格法規給製造商和醫療保健提供者帶來了合規負擔，影響了市場進入障礙和營運成本。此外，診斷測試的報銷範圍有限以及先進診斷設備的高成本對市場滲透構成了挑戰，特別是在醫療保健預算有限的新興國家。解決這些監管和經濟障礙需要行業利益相關者和政策制定者之間的合作，以促進獲得準確且負擔得起的診斷解決方案。

市場機會：

由於技術創新、人口趨勢和不斷發展的醫療保健服務模式，流感診斷市場呈現出巨大的成長機會。遠端監控和遠距醫療平台等數位醫療技術的集成，增加了患者獲得診斷服務的機會，並提高了治療依從性和結果。此外，擴大流感以外的診斷應用，例如檢測其他呼吸道病毒和傳染病，將擴大市場範圍並促進創新。策略合作夥伴關係、研發投資以及推出用戶友好且具有成本效益的診斷解決方案對於利用新的商機並保持在動態診斷市場的領先地位至關重要。

本報告解決的關鍵問題

  • 推動全球流感診斷市場成長的關鍵因素是什麼？
  • 哪些診斷類型和應用正在推動各種醫療機構中的流感診斷？
  • 科技進步如何改變流感診斷市場的競爭格局？
  • 誰是流感診斷市場的主要參與者？
  • 全球流感診斷市場的新趨勢和未來前景是什麼？

目錄

第1章 摘要整理

第2章 市場概要

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 蘊藏事項·除外事項

第3章 主要市場趨勢

  • 影響市場的主要趨勢
  • 產品革新/開發趨勢

第4章 主要成功因素

  • 產品的採用/使用情形分析
  • 產品的USP/特徵
  • 策略和推銷策略
  • 主要的法規
  • 疾病流行病學
  • 大環境分析
  • 波特分析

第5章 市場背景

  • 宏觀經濟要素
  • 預測要素 - 相關性及影響
  • 動態

第6章 COVID-19危機分析

  • COVID-19及影響分析
    • 檢查別
    • 各流感類型
    • 各終端用戶
  • 2024年的市場情勢

第7章 全球流感診斷市場需求(金額或規模，10億美元)分析

  • 過去的市場金額(10億美元)的分析，2019年～2023年
  • 現在及未來市場金額(10億美元)預測，2024年～2033年
    • 前一年同期比較成長趨勢分析
    • 絕對額的機會分析

第8章 全球流感診斷市場分析:檢查別

  • 簡介/主要調查結果
  • 過去的市場規模(10億美元)的分析:檢查別，2019年～2023年
  • 現在及未來市場規模(10億美元)的分析與預測:檢查別，2024年～2033年
    • 分子診斷檢驗
    • 傳統的診斷試驗
  • 市場魅力分析:檢查別

第9章 全球流感診斷市場分析:各流感類型

  • 簡介/主要調查結果
  • 過去的市場規模(10億美元)的分析:各流感類型，2019年～2023年
  • 現在及未來市場規模(10億美元)的分析與預測:各流感類型，2024年～2033年
    • A型流感
    • B型流感
    • C型流感
  • 市場魅力分析:各流感類型

第10章 全球流感診斷市場分析:各終端用戶

  • 簡介/主要調查結果
  • 過去的市場規模(10億美元)的分析:各終端用戶，2019年～2023年
  • 現在及未來市場規模(10億美元)的分析與預測:各終端用戶，2024年～2033年
    • 醫院
    • 診斷檢驗室
    • 研究·學術機構
    • 契約調查機關(CRO)
  • 市場魅力分析:各終端用戶

第11章 全球流感診斷市場分析:各地區

  • 簡介
  • 過去的市場規模(10億美元)的分析:各地區，2019年～2023年
  • 現在及未來市場規模(10億美元)的分析與預測:各地區，2024年～2033年
    • 北美
    • 南美
    • 歐洲
    • 南亞
    • 東亞
    • 大洋洲
    • 中東·非洲(MEA)
  • 市場魅力分析:各地區

第12章 北美的流感診斷市場分析

第13章 南美的流感診斷市場分析

第14章 歐洲的流感診斷市場分析

第15章 南亞的流感診斷市場分析

第16章 東亞的流感診斷市場分析

第17章 大洋洲的流感診斷市場分析

第18章 中東·非洲的流感診斷市場分析

第19章 市場結構分析

  • 市場分析:企業各層級
  • 主要企業的市場佔有率分析
  • 市場集中
  • 市場影響分析

第20章 競爭分析

  • 競爭儀表板
  • 競爭的詳細資訊
    • Abbott Laboratories
    • Endress+Hauser(Analytik Jena AG)
    • Becton, Dickinson and Company
    • Biocartis
    • bioMerieux Inc
    • Danaher Corporation(Cepheid)
    • F. Hoffmann-La Roche Ltd
    • GenMark Diagnostics, Inc.
    • Luminex Corporation
    • Meridian Bioscience, Inc
    • Quidel Corporation
    • Thermo Fisher Scientific Inc.
    • Hologic

第21章 所使用的前提條件與縮寫

第22章 調查手法

簡介目錄
Product Code: PMRREP13246

Persistence Market Research has recently released a comprehensive report on the worldwide market for influenza diagnostics. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Influenza Diagnostics Market Size (2024E): USD 1.8 Billion
  • Projected Market Value (2033F): USD 3.0 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 6.1%

Influenza Diagnostics Market - Report Scope:

Influenza diagnostics play a crucial role in the early detection, treatment, and management of influenza infections. These diagnostics include rapid influenza diagnostic tests (RIDTs), reverse transcription-polymerase chain reaction (RT-PCR) assays, and other molecular diagnostic tools. The market serves hospitals, clinics, diagnostic laboratories, and homecare settings, offering a range of diagnostic devices that provide timely and accurate results to manage influenza outbreaks effectively.

Market growth is driven by increasing prevalence of influenza, rising healthcare expenditures, and advancements in diagnostic technology, enhancing detection accuracy and reducing diagnostic time.

Market Growth Drivers:

The global influenza diagnostics market is propelled by several key factors, including growing awareness about early diagnosis and treatment of influenza to prevent complications and transmission. The rising incidence of influenza infections, coupled with the demand for effective diagnostic solutions during seasonal outbreaks, further drives market expansion. Technological advancements, such as the development of highly sensitive and specific molecular diagnostic tools, offer improved detection rates and shorter turnaround times, fostering market growth. Moreover, the increasing adoption of point-of-care testing and home-based diagnostic solutions creates new avenues for market players to reach a wider patient population.

Market Restraints:

Despite promising growth prospects, the influenza diagnostics market faces challenges related to regulatory compliance, reimbursement policies, and competition from alternative diagnostic methods. Stringent regulations governing the manufacturing, marketing, and use of diagnostic devices impose compliance burdens on manufacturers and healthcare providers, affecting market entry barriers and operational costs. Furthermore, limited reimbursement coverage for diagnostic tests and the high cost of advanced diagnostic equipment pose challenges for market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these regulatory and economic barriers requires collaboration between industry stakeholders and policymakers to promote access to accurate and affordable diagnostic solutions.

Market Opportunities:

The influenza diagnostics market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of digital health technologies, such as remote monitoring and telemedicine platforms, enhances patient access to diagnostic services and improves treatment adherence and outcomes. Furthermore, the expanding application of diagnostics beyond influenza, including in the detection of other respiratory viruses and infections, broadens the market scope and stimulates innovation. Strategic partnerships, investment in research and development, and the introduction of user-friendly, cost-effective diagnostic solutions are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic diagnostics landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the influenza diagnostics market globally?
  • Which diagnostic types and applications are driving influenza diagnosis across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the influenza diagnostics market?
  • Who are the key players contributing to the influenza diagnostics market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global influenza diagnostics market?

Competitive Intelligence and Business Strategy:

Leading players in the global influenza diagnostics market, including Roche Diagnostics, Abbott Laboratories, and Quidel Corporation, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced diagnostic solutions, including molecular assays and point-of-care tests, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, diagnostic laboratories, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving diagnostics landscape.

Key Companies Profiled:

  • Abbott Laboratories
  • Endress+Hauser (Analytik Jena AG)
  • Becton, Dickinson and Company
  • Biocartis
  • bioMerieux Inc
  • Danaher Corporation (Cepheid)
  • F. Hoffmann-La Roche Ltd
  • GenMark Diagnostics, Inc.
  • Luminex Corporation
  • Meridian Bioscience, Inc
  • Quidel Corporation
  • Thermo Fisher Scientific Inc.
  • Hologic

Key Segments Covered in Influenza Diagnostics Industry Research

Test:

  • Molecular Diagnostic Test
  • Traditional Diagnostic Test

Type of Flu:

  • Type A Flu
  • Type B Flu
  • Type C Flu

End User:

  • Hospitals
  • Diagnostic Laboratories
  • Research & Academic Institute
  • Contract Research Organization (CRO's)

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Strategic and Promotional Strategies
  • 4.4. Key Regulations
  • 4.5. Disease Epidemiology
  • 4.6. PESTLE Analysis
  • 4.7. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Market Outlook
    • 5.1.3. Global Infectious Disease Diagnostics Market Overview
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Top Influenza Diagnostics Companies & their Historical Growth
    • 5.2.2. Application Innovation in Influenza Diagnostics
    • 5.2.3. Product Adoption Rate
    • 5.2.4. Regulatory Impositions
    • 5.2.5. Growing R&D Investments
    • 5.2.6. Novel Diagnostic Product Development Activities
    • 5.2.7. Awareness Campaigns for Influenza Diagnostics
  • 5.3. Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Test
    • 6.1.2. By Type of Flu
    • 6.1.3. By End User
  • 6.2. 2024 Market Scenario

7. Global Influenza Diagnostics Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, By Test

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis By Test, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Test, 2024-2033
    • 8.3.1. Molecular Diagnostics Tests
      • 8.3.1.1. RT-PCR
      • 8.3.1.2. LAMP
      • 8.3.1.3. NASABA
    • 8.3.2. Traditional Diagnostics Tests
      • 8.3.2.1. Rapid Influenza Detection Kits
      • 8.3.2.2. Serological Assays
      • 8.3.2.3. Direct Fluorescent Antibody
      • 8.3.2.4. Viral Culture
      • 8.3.2.5. H1N1 Influenza A Virus Identification Kits
      • 8.3.2.6. Immunoassay Kits
      • 8.3.2.7. Immunofluorescence Antibody Assay
  • 8.4. Market Attractiveness Analysis By Test

9. Global Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, By Type of Flu

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis By Type of Flu, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Type of Flu, 2024-2033
    • 9.3.1. Type A Flu
    • 9.3.2. Type B Flu
    • 9.3.3. Type C Flu
  • 9.4. Market Attractiveness Analysis By Type of Flu

10. Global Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, by End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 10.3.1. Hospitals
    • 10.3.2. Diagnostic Laboratories
    • 10.3.3. Research & Academic Institutes
    • 10.3.4. Contract Research Organizations (CRO)
  • 10.4. Market Attractiveness Analysis By End User

11. Global Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. South Asia
    • 11.3.5. East Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis By Region

12. North America Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Test
    • 12.3.3. By Type of Flu
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Test
    • 12.4.3. By Type of Flu
    • 12.4.4. By End User
  • 12.5. Country Level Analysis & Forecast
    • 12.5.1. U.S. Influenza Diagnostics Market Analysis
      • 12.5.1.1. Introduction
      • 12.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.1.2.1. By Test
        • 12.5.1.2.2. By Type of Flu
        • 12.5.1.2.3. By End User
    • 12.5.2. Canada Influenza Diagnostics Market Analysis
      • 12.5.2.1. Introduction
      • 12.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.2.2.1. By Test
        • 12.5.2.2.2. By Type of Flu
        • 12.5.2.2.3. By End User
  • 12.6. Market Trends
  • 12.7. Key Market Participants - Intensity Mapping
  • 12.8. Drivers and Restraints - Impact Analysis
  • 12.9. Country Level Analysis & Forecast

13. Latin America Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Mexico
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Test
    • 13.3.3. By Type of Flu
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Test
    • 13.4.3. By Type of Flu
    • 13.4.4. By End User
  • 13.5. Country Level Analysis & Forecast
    • 13.5.1. Brazil Influenza Diagnostics Market Analysis
      • 13.5.1.1. Introduction
      • 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.1.2.1. By Test
        • 13.5.1.2.2. By Type of Flu
        • 13.5.1.2.3. By End User
    • 13.5.2. Mexico Influenza Diagnostics Market Analysis
      • 13.5.2.1. Introduction
      • 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.2.2.1. By Test
        • 13.5.2.2.2. By Type of Flu
        • 13.5.2.2.3. By End User
    • 13.5.3. Argentina Influenza Diagnostics Market Analysis
      • 13.5.3.1. Introduction
      • 13.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.3.2.1. By Test
        • 13.5.3.2.2. By Type of Flu
        • 13.5.3.2.3. By End User
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis
  • 13.9. Country Level Analysis & Forecast

14. Europe Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. France
      • 14.3.1.3. Italy
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. Russia
      • 14.3.1.7. BENELUX
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Test
    • 14.3.3. By Type of Flu
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Test
    • 14.4.3. By Type of Flu
    • 14.4.4. By End User
  • 14.5. Country Level Analysis & Forecast
    • 14.5.1. Germany Influenza Diagnostics Market Analysis
      • 14.5.1.1. Introduction
      • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.1.2.1. By Test
        • 14.5.1.2.2. By Type of Flu
        • 14.5.1.2.3. By End User
    • 14.5.2. France Influenza Diagnostics Market Analysis
      • 14.5.2.1. Introduction
      • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.2.2.1. By Test
        • 14.5.2.2.2. By Type of Flu
        • 14.5.2.2.3. By End User
    • 14.5.3. Italy Influenza Diagnostics Market Analysis
      • 14.5.3.1. Introduction
      • 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.3.2.1. By Test
        • 14.5.3.2.2. By Type of Flu
        • 14.5.3.2.3. By End User
    • 14.5.4. U.K. Influenza Diagnostics Market Analysis
      • 14.5.4.1. Introduction
      • 14.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.4.2.1. By Test
        • 14.5.4.2.2. By Type of Flu
        • 14.5.4.2.3. By End User
    • 14.5.5. Spain Influenza Diagnostics Market Analysis
      • 14.5.5.1. Introduction
      • 14.5.5.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.5.2.1. By Test
        • 14.5.5.2.2. By Type of Flu
        • 14.5.5.2.3. By End User
    • 14.5.6. Russia Influenza Diagnostics Market Analysis
      • 14.5.6.1. Introduction
      • 14.5.6.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.6.2.1. By Test
        • 14.5.6.2.2. By Type of Flu
        • 14.5.6.2.3. By End User
    • 14.5.7. BENELUX Influenza Diagnostics Market Analysis
      • 14.5.7.1. Introduction
      • 14.5.7.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.7.2.1. By Test
        • 14.5.7.2.2. By Type of Flu
        • 14.5.7.2.3. By End User
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis
  • 14.9. Country Level Analysis & Forecast

15. South Asia Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Thailand
      • 15.3.1.3. Indonesia
      • 15.3.1.4. Malaysia
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Test
    • 15.3.3. By Type of Flu
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Test
    • 15.4.3. By Type of Flu
    • 15.4.4. By End User
  • 15.5. Country Level Analysis & Forecast
    • 15.5.1. India Influenza Diagnostics Market Analysis
      • 15.5.1.1. Introduction
      • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.1.2.1. By Test
        • 15.5.1.2.2. By Type of Flu
        • 15.5.1.2.3. By End User
    • 15.5.2. Thailand Influenza Diagnostics Market Analysis
      • 15.5.2.1. Introduction
      • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.2.2.1. By Test
        • 15.5.2.2.2. By Type of Flu
        • 15.5.2.2.3. By End User
    • 15.5.3. Indonesia Influenza Diagnostics Market Analysis
      • 15.5.3.1. Introduction
      • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.3.2.1. By Test
        • 15.5.3.2.2. By Type of Flu
        • 15.5.3.2.3. By End User
    • 15.5.4. Malaysia Influenza Diagnostics Market Analysis
      • 15.5.4.1. Introduction
      • 15.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.4.2.1. By Test
        • 15.5.4.2.2. By Type of Flu
        • 15.5.4.2.3. By End User
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis
  • 15.9. Country Level Analysis & Forecast

16. East Asia Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Test
    • 16.3.3. By Type of Flu
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Test
    • 16.4.3. By Type of Flu
    • 16.4.4. By End User
  • 16.5. Country Level Analysis & Forecast
    • 16.5.1. China Influenza Diagnostics Market Analysis
      • 16.5.1.1. Introduction
      • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.1.2.1. By Test
        • 16.5.1.2.2. By Type of Flu
        • 16.5.1.2.3. By End User
    • 16.5.2. Japan Influenza Diagnostics Market Analysis
      • 16.5.2.1. Introduction
      • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.2.2.1. By Test
        • 16.5.2.2.2. By Type of Flu
        • 16.5.2.2.3. By End User
    • 16.5.3. South Korea Influenza Diagnostics Market Analysis
      • 16.5.3.1. Introduction
      • 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.3.2.1. By Test
        • 16.5.3.2.2. By Type of Flu
        • 16.5.3.2.3. By End User
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis
  • 16.9. Country Level Analysis & Forecast

17. Oceania Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Test
    • 17.3.3. By Type of Flu
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Test
    • 17.4.3. By Type of Flu
    • 17.4.4. By End User
  • 17.5. Country Level Analysis & Forecast
    • 17.5.1. Australia Influenza Diagnostics Market Analysis
      • 17.5.1.1. Introduction
      • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.1.2.1. By Test
        • 17.5.1.2.2. By Type of Flu
        • 17.5.1.2.3. By End User
    • 17.5.2. New Zealand Influenza Diagnostics Market Analysis
      • 17.5.2.1. Introduction
      • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.2.2.1. By Test
        • 17.5.2.2.2. By Type of Flu
        • 17.5.2.2.3. By End User
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis
  • 17.9. Country Level Analysis & Forecast

18. Middle East and Africa Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkey
      • 18.3.1.3. South Africa
      • 18.3.1.4. North Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Test
    • 18.3.3. By Type of Flu
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Test
    • 18.4.3. By Type of Flu
    • 18.4.4. By End User
  • 18.5. Country Level Analysis & Forecast
    • 18.5.1. GCC Countries Influenza Diagnostics Market Analysis
      • 18.5.1.1. Introduction
      • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.1.2.1. By Test
        • 18.5.1.2.2. By Type of Flu
        • 18.5.1.2.3. By End User
    • 18.5.2. Turkey Influenza Diagnostics Market Analysis
      • 18.5.2.1. Introduction
      • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.2.2.1. By Test
        • 18.5.2.2.2. By Type of Flu
        • 18.5.2.2.3. By End User
    • 18.5.3. South Africa Influenza Diagnostics Market Analysis
      • 18.5.3.1. Introduction
      • 18.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.3.2.1. By Test
        • 18.5.3.2.2. By Type of Flu
        • 18.5.3.2.3. By End User
    • 18.5.4. North Africa Influenza Diagnostics Market Analysis
      • 18.5.4.1. Introduction
      • 18.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.4.2.1. By Test
        • 18.5.4.2.2. By Type of Flu
        • 18.5.4.2.3. By End User
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Market Trends
  • 18.8. Key Market Participants - Intensity Mapping
  • 18.9. Country Level Analysis & Forecast

19. Market Structure Analysis

  • 19.1. Market Analysis by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Concentration
  • 19.4. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Deep Dive
    • 20.2.1. Abbott Laboratories
      • 20.2.1.1. Overview
      • 20.2.1.2. Product Portfolio
      • 20.2.1.3. Key Financials
      • 20.2.1.4. Sales Footprint
      • 20.2.1.5. Strategy Overview
        • 20.2.1.5.1. Marketing Strategy
        • 20.2.1.5.2. Product Strategy
        • 20.2.1.5.3. Channel Strategy
    • 20.2.2. Endress+Hauser (Analytik Jena AG)
      • 20.2.2.1. Overview
      • 20.2.2.2. Product Portfolio
      • 20.2.2.3. Key Financials
      • 20.2.2.4. Sales Footprint
      • 20.2.2.5. Strategy Overview
        • 20.2.2.5.1. Marketing Strategy
        • 20.2.2.5.2. Product Strategy
        • 20.2.2.5.3. Channel Strategy
    • 20.2.3. Becton, Dickinson and Company
      • 20.2.3.1. Overview
      • 20.2.3.2. Product Portfolio
      • 20.2.3.3. Key Financials
      • 20.2.3.4. Sales Footprint
      • 20.2.3.5. Strategy Overview
        • 20.2.3.5.1. Marketing Strategy
        • 20.2.3.5.2. Product Strategy
        • 20.2.3.5.3. Channel Strategy
    • 20.2.4. Biocartis
      • 20.2.4.1. Overview
      • 20.2.4.2. Product Portfolio
      • 20.2.4.3. Key Financials
      • 20.2.4.4. Sales Footprint
      • 20.2.4.5. Strategy Overview
        • 20.2.4.5.1. Marketing Strategy
        • 20.2.4.5.2. Product Strategy
        • 20.2.4.5.3. Channel Strategy
    • 20.2.5. bioMerieux Inc
      • 20.2.5.1. Overview
      • 20.2.5.2. Product Portfolio
      • 20.2.5.3. Key Financials
      • 20.2.5.4. Sales Footprint
      • 20.2.5.5. Strategy Overview
        • 20.2.5.5.1. Marketing Strategy
        • 20.2.5.5.2. Product Strategy
        • 20.2.5.5.3. Channel Strategy
    • 20.2.6. Danaher Corporation (Cepheid)
      • 20.2.6.1. Overview
      • 20.2.6.2. Product Portfolio
      • 20.2.6.3. Key Financials
      • 20.2.6.4. Sales Footprint
      • 20.2.6.5. Strategy Overview
        • 20.2.6.5.1. Marketing Strategy
        • 20.2.6.5.2. Product Strategy
        • 20.2.6.5.3. Channel Strategy
    • 20.2.7. F. Hoffmann-La Roche Ltd
      • 20.2.7.1. Overview
      • 20.2.7.2. Product Portfolio
      • 20.2.7.3. Key Financials
      • 20.2.7.4. Sales Footprint
      • 20.2.7.5. Strategy Overview
        • 20.2.7.5.1. Marketing Strategy
        • 20.2.7.5.2. Product Strategy
        • 20.2.7.5.3. Channel Strategy
    • 20.2.8. GenMark Diagnostics, Inc.
      • 20.2.8.1. Overview
      • 20.2.8.2. Product Portfolio
      • 20.2.8.3. Key Financials
      • 20.2.8.4. Sales Footprint
      • 20.2.8.5. Strategy Overview
        • 20.2.8.5.1. Marketing Strategy
        • 20.2.8.5.2. Product Strategy
        • 20.2.8.5.3. Channel Strategy
    • 20.2.9. Luminex Corporation
      • 20.2.9.1. Overview
      • 20.2.9.2. Product Portfolio
      • 20.2.9.3. Key Financials
      • 20.2.9.4. Sales Footprint
      • 20.2.9.5. Strategy Overview
        • 20.2.9.5.1. Marketing Strategy
        • 20.2.9.5.2. Product Strategy
        • 20.2.9.5.3. Channel Strategy
    • 20.2.10. Meridian Bioscience, Inc
      • 20.2.10.1. Overview
      • 20.2.10.2. Product Portfolio
      • 20.2.10.3. Key Financials
      • 20.2.10.4. Sales Footprint
      • 20.2.10.5. Strategy Overview
        • 20.2.10.5.1. Marketing Strategy
        • 20.2.10.5.2. Product Strategy
        • 20.2.10.5.3. Channel Strategy
    • 20.2.11. Quidel Corporation
      • 20.2.11.1. Overview
      • 20.2.11.2. Product Portfolio
      • 20.2.11.3. Key Financials
      • 20.2.11.4. Sales Footprint
      • 20.2.11.5. Strategy Overview
        • 20.2.11.5.1. Marketing Strategy
        • 20.2.11.5.2. Product Strategy
        • 20.2.11.5.3. Channel Strategy
    • 20.2.12. Thermo Fisher Scientific Inc.
      • 20.2.12.1. Overview
      • 20.2.12.2. Product Portfolio
      • 20.2.12.3. Key Financials
      • 20.2.12.4. Sales Footprint
      • 20.2.12.5. Strategy Overview
        • 20.2.12.5.1. Marketing Strategy
        • 20.2.12.5.2. Product Strategy
        • 20.2.12.5.3. Channel Strategy
    • 20.2.13. Hologic
      • 20.2.13.1. Overview
      • 20.2.13.2. Product Portfolio
      • 20.2.13.3. Key Financials
      • 20.2.13.4. Sales Footprint
      • 20.2.13.5. Strategy Overview
        • 20.2.13.5.1. Marketing Strategy
        • 20.2.13.5.2. Product Strategy
        • 20.2.13.5.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology